You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Antimicrobial Resistance (AMR)

Test Information
Home / Tests / Critical Infectious Diseases / Xpert Xpress CoV-2/Flu/RSV plus

Xpert® Xpress CoV-2/Flu/RSV plus

Actionable, rapid respiratory results to meet the challenges of the ongoing pandemic.

Xpert<sup>®&nbsp;</sup>Xpress CoV-2/Flu/RSV <em>plus</em>

The Need


  • Rapidly detect SARS-CoV-2, including emerging variants, to provide timely, effective triage.
  • Accurately diagnose respiratory tract infections to ensure appropriate treatment.
  • Rapidly differentiate flu, RSV, and SARS-CoV-2 and potential co-infections during respiratory season.

The Solution


  • Robust design with three distinct gene targets for SARS-CoV-2: N2, E, RdRP.
  • Accurate detection and differentiation of SARS-CoV-2, Flu A, Flu B, and RSV. Results for SARS-CoV-2 in as little as 25 minutes.^
  • Actionable results from a single sample with less than one minute of hands-on time.
  • Standardization of results between the central lab and near-patient testing sites.

The Impact


  • 3-gene design supports clinicians with broader coverage for SARS-CoV-2 variants.
  • Ensures that patients receive appropriate treatment in a timely manner.
  • Single cartridge with an easy-to-use workflow, enabling effective management of limited resources.

For Use Under an Emergency Use Authorization (EUA) only. This test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Full test runtime is 36 minutes. SARS-CoV-2 positive results available in as soon as 25 minutes with early assay termination.

Ordering Info


Xpert® Xpress CoV-2/Flu/RSV plus

Number of Tests: 10  

Catalog #: XP3COV2/FLU/RSV-10

Frequently Asked Questions

How is the Xpert Xpress CoV-2/Flu/RSV plus product different from the existing Xpert Xpress SARS-CoV-2/Flu/RSV product?

What sample types and collection devices can be used with Xpert Xpress CoV-2/Flu/RSV plus?

What are my options for Viral Transport Media for Xpert Xpress CoV-2/Flu/RSV plus?

What external quality control (QC) material options are available for Xpert Xpress CoV-2/Flu/RSV plus?

What are the requirements for verification and what guidelines do you have for transitioning from my current Cepheid's Xpert Xpress SARS-CoV-2 and/or Xpert Xpress SARS-CoV-2/Flu/RSV to Xpert Xpress CoV-2/Flu/RSV plus?

Why isn’t there a CD with the ADF nor a Package Insert in my Xpert Xpress CoV-2/Flu/RSV plus test kit?

Back to Top